These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 6974264
21. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype. Steinmuller D, Tyler JD, David CS. J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477 [No Abstract] [Full Text] [Related]
22. Lyt phenotypes of responding cells in secondary alloantigen responses. Alter BJ, Bach FH. J Immunol; 1979 Dec; 123(6):2599-601. PubMed ID: 159321 [Abstract] [Full Text] [Related]
23. Muscarinic cholinergic activation of mouse spleen cells cytotoxic to tumor cells in vitro. Lane MA. J Natl Cancer Inst; 1978 Sep; 61(3):923-6. PubMed ID: 29133 [Abstract] [Full Text] [Related]
24. Induction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection. Pope M, Kotlarski I, Doherty K. Immunology; 1994 Feb; 81(2):177-82. PubMed ID: 7512524 [Abstract] [Full Text] [Related]
31. H-2 I alloantigens and recall of memory cytotoxic responses. Orosz CG, Macphail S, Bach FH. J Supramol Struct; 1980 Feb; 14(1):121-7. PubMed ID: 6971370 [Abstract] [Full Text] [Related]
32. Surface markers on the T cells that regulate cytotoxic T cell responses. II. Distribution of Ly 6.1 and Ly 7.2: selective expression of Ly 7.2 on helper T cell effectors. Pilarski LM, Al-Adra AR, McKenzie IF. J Immunol; 1980 Jul; 125(1):365-9. PubMed ID: 6966658 [Abstract] [Full Text] [Related]
33. Characteristics of xenograft rejection. I. Augmented cytotoxicity of peritoneal T cells after intraperitoneal injection of booster antigen and/or proteose peptone. Terasaka R, Himeno K, Shiraishi M, Nomoto K. Jpn J Exp Med; 1981 Apr; 51(2):75-80. PubMed ID: 6974262 [Abstract] [Full Text] [Related]
34. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. Curtsinger JM, Lins DC, Mescher MF. J Immunol; 1998 Apr 01; 160(7):3236-43. PubMed ID: 9531279 [Abstract] [Full Text] [Related]
35. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype. Lamousé-Smith E, McCarthy SA. Cell Immunol; 1997 Aug 01; 179(2):107-15. PubMed ID: 9268494 [Abstract] [Full Text] [Related]
36. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. Shier P, Ngo K, Fung-Leung WP. J Immunol; 1999 Nov 01; 163(9):4826-32. PubMed ID: 10528183 [Abstract] [Full Text] [Related]
37. Characterization of the target antigen of F1 anti-parent cytotoxic lympholysis: analysis of the spontaneous in vitro F1 cytotoxic T lymphocytes. Ishikawa H, Dutton RW. J Immunol; 1980 Aug 01; 125(2):656-62. PubMed ID: 6967085 [No Abstract] [Full Text] [Related]
38. Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity. Akporiaye ET, Kudalore M, Stevenson AP, Kraemer PM, Stewart CC. Cancer Res; 1988 Mar 01; 48(5):1153-8. PubMed ID: 3257713 [Abstract] [Full Text] [Related]
39. Regulation of human cytotoxic lymphocyte responses. I. Non-cytolytic suppression mediated by alloantigen-activated cells. Crosier PS, Broom BC. Immunology; 1981 May 01; 43(1):11-8. PubMed ID: 6454646 [Abstract] [Full Text] [Related]